No Data
No Data
EMINENCE ENT (00616.HK) received a shareholding increase of 73.5978 million ordinary shares from Luo Shihong, valued at approximately 7.5217 million Hong Kong dollars.
On February 7, it was reported that according to the documents disclosed by the Hong Kong Stock Exchange on February 7, Luo Shihong increased his shareholding in EMINENCE ENT (00616.HK) by 73.5978 million ordinary shares at an average price of HKD 0.1022 per share on February 5, valued at approximately HKD 7.5217 million. After the shareholding increase, Luo Shihong's latest number of shares held is 98.8978 million shares, with the good stock ratio rising from 2.49% to 9.75%. Image source: Stock Disclosure by the Exchange What is equity disclosure? According to the requirements of the Hong Kong Stock Exchange, major shareholders (individuals and companies holding 5% or more) must disclose their shareholding in listed companies.
EMINENCE ENT (00616.HK) received a shareholding of 0.128 billion ordinary shares from Zhu Nianyao in the over-the-counter market, valued at approximately 11.7756 million Hong Kong dollars.
On February 6, it was reported that according to documents disclosed by the Hong Kong Stock Exchange on February 6, Zhu Nianyao increased shareholding in EMINENCE ENT (00616.HK) by 0.128 billion shares at an average price of HKD 0.092 per share on February 4, amounting to approximately HKD 11.7756 million. After the shareholding increase, Zhu Nianyao's latest number of shares held is 0.161 billion, and the ratio of good holdings increased from 9.86% to 15.90%. Additional information: Acquired 66,660,000 shares through acceptances of rights.
EMINENCE ENT (00616) issued 0.676 billion shares for the rights issue.
EMINENCE ENT (00616) released an announcement that the company will conduct a rights issue on February 4, 2025, based on the record date each...
EMINENCE ENT (00616.HK) has received an oversubscription of about 2.54% for its share offering.
Gelonghui reported on February 3 that EMINENCE ENT (00616.HK) announced that the rights issue became unconditional on January 28, 2025. On January 22, 2025, at 4:00 PM, a total of 25 valid acceptances and applications were received, involving 693,496,999 shares of the rights issue, which is approximately 102.54% of the total 676,296,232 shares available for subscription under the rights issue. Therefore, the rights issue was oversubscribed by 17,200,767 shares, which is about 2.54% of the total 676,296,232 shares available for subscription under the rights issue.
Lai Si Enterprise Buys Hong Kong Property
LAI SI ENT (02266.HK) spent over 10.35 million yuan to purchase commercial properties in Cheung Sha Wan from EMINENCE ENT (00616.HK).
LAI SI ENT (02266.HK) announced that its wholly-owned subsidiary Nice Contracting Limited, as the buyer, signed a preliminary agreement today (2nd) with EMINENCE ENT (00616.HK) to acquire a commercial property owned by Kangtu Development at a price of 10.3575 million yuan. It is expected that both parties will sign a formal agreement on or before next Thursday (9th), and the Trade will be completed on or before March 21 this year. The property is located at Room 1, 7th Floor, One Two One, 121 Qionglin Street, Cheung Sha Wan, with a total floor area of approximately 1,566 square feet.